Lymphomas following cardiac transplantation. Case report and review of the literature
Authors:
- 1 June 1991
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 37 (2) , 105-111
Abstract
The success of allogeneic organ transplantation is in great part due to pharmacologic advances in the area of immunosuppressive therapy. However, this achievement has been attained at the price of an unexpectedly high incidence of malignancies in this transplant population. Lymphoid malignancies predominate in this and other immunodeficiency states. There is some controversy in the literature over the clonal or malignant nature of these proliferations. This paper presents a case of Burkitt‐like lymphoma occurring after cardiac transplantation. The role of Epstein–Barr virus in the pathogenesis of this disorder is reviewed as are multidisciplinary approaches to its management.Keywords
This publication has 21 references indexed in Scilit:
- CyclosporineNew England Journal of Medicine, 1989
- Comparison of Three Immunosuppressive Regimens in Cadaver Renal Transplantation: Long-Term Cyclosporine, Short-Term Cyclosporine Followed by Azathioprine and Prednisolone, and Azathioprine and Prednisolone without CyclosporineNew England Journal of Medicine, 1988
- Prophylactic Acyclovir in Patients Receiving Bone Marrow TransplantsNew England Journal of Medicine, 1985
- Epstein–Barr Virus–Associated B-Cell Proliferations of Diverse Clonal Origins after Bone Marrow Transplantation in a 12-Year-Old Patient with Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1985
- Epstein–Barr-Virus Induced LymphoproliferationNew England Journal of Medicine, 1984
- LYMPHOPROLIFERATIVE DISORDERS IN CARDIAC TRANSPLANT RECIPIENTS ARE MULTICLONAL LYMPHOMASThe Lancet, 1984
- Monoclonality of Lymphoproliferative Lesions in Cardiac-Transplant RecipientsNew England Journal of Medicine, 1984
- Epstein–Barr Virus-Induced B-Cell Lymphoma after Renal TransplantationNew England Journal of Medicine, 1982
- LYMPHOMA IN CARDIAC ALLOTRANSPLANT RECIPIENTSTransplantation, 1982
- IDIOPATHIC CARDIOMYOPATHY, AGE, AND SUPPRESSOR-CELL DYSFUNCTION AS RISK DETERMINANTS OF LYMPHOMA AFTER CARDIAC TRANSPLANTATIONThe Lancet, 1978